Clindamycin (as Phosphate) 150 mg/mL (600 mg/4 mL) Solution for Injection (I.M./I.V.) (Amsocyn-600)

Clindamycin (as Phosphate) 150 mg/mL (600 mg/4 mL) Solution for Injection (I.M./I.V.) (Amsocyn-600)

Clindamycin (as Phosphate) 150 mg/mL (600 mg/4 mL) Solution for Injection (I.M./I.V.) (Amsocyn-600)

FORMULATION:
Each mL ampoule contains: Clindamycin (as Phosphate) USP.
PRODUCT DESCRIPTION: 150 mg AMSOCYN-600(Clindamycin phosphate) is a colorless clear solution.
INDICATIONS:
Antibacterial. Serious infections caused by susceptible Gram-positive organisms, staphylococci (both penicillinase- and non-penicillinase-producing), streptococci (except Streptococcus faecalis) and pneumococci. It is also indicated in serious infections caused by susceptible anaerobic pathogens such as Bacteroides spp, Fusobacterium spp, Propionibacterium spp, Peptostreptococcus spp. and microaerophilic streptococci. Clindamycin does not penetrate the blood/brain barrier in therapeutically effective quantities.
Pack Size: 10’s (4 mL Ampule)
Exp: Oct 2025
Carton Size: 90 boxes

Clindamycin (as Phosphate) 150 mg/mL (600 mg/4 mL) Solution for Injection (I.M./I.V.) (Amsocyn-600)

FORMULATION:
Each mL ampoule contains: Clindamycin (as Phosphate) USP.
PRODUCT DESCRIPTION: 150 mg AMSOCYN-600(Clindamycin phosphate) is a colorless clear solution.
INDICATIONS:
Antibacterial. Serious infections caused by susceptible Gram-positive organisms, staphylococci (both penicillinase- and non-penicillinase-producing), streptococci (except Streptococcus faecalis) and pneumococci. It is also indicated in serious infections caused by susceptible anaerobic pathogens such as Bacteroides spp, Fusobacterium spp, Propionibacterium spp, Peptostreptococcus spp. and microaerophilic streptococci. Clindamycin does not penetrate the blood/brain barrier in therapeutically effective quantities.
Pack Size: 10’s (4 mL Ampule)
Exp: Oct 2025
Carton Size: 90 boxes

Contact Us!

Category:

Download Our Product List